Old Roche R&D campus in NJ faces the wrecking ball

Once upon a time Roche's ($RHBBY) sprawling R&D campus in Nutley, NJ, was considered one of the top research hubs in the world. But a lengthy track record of setbacks and the acquisition of Genentech in California changed all that, and the pharma giant shuttered the site and moved a group of survivors into a new research facility in Manhattan. Now the Star-Ledger reports that developers are razing most of the 40 buildings in the complex, prepping for a sale of the campus either as one parcel or building-by-remaining-building. Story

Suggested Articles

A new, late-phase analysis of cholesterol-lowering inclisiran showed that it was able to cut LDL levels by 51% after nearly a year and a half.

The data were highly anticipated, especially since the two partners continued testing after the compound missed its endpoints in phase 2 studies.

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.